መነሻ › ኦስትዮሳርኮማ › ዲስትሪክት ኦፍ ኮሎምቢያ
በዲስትሪክት ኦፍ ኮሎምቢያ ለኦስትዮሳርኮማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለኦስትዮሳርኮማ የሚደረጉ 5 ጥናቶች በዲስትሪክት ኦፍ ኮሎምቢያ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በዲስትሪክት ኦፍ ኮሎምቢያ ውስጥ ያሉ ከተሞች
Official study text (English)
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ12 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT04616560Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 3
እስከ እድሜ 50 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT05235165Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ19 ሜይ 2026 · NCT04901702A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's National Medical Center, Washington D.C.
ተሳታዮችን በመፈለግ ላይደረጃ 2
18 Months – 40 Years · ሁሉም ጾታዎች · የተሻሻለው በ12 ኦገስ 2025 · NCT05135975ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።